Xcout Intel
ARTHEx Biotech competitors & alternatives
The 12 closest competitors and alternatives to ARTHEx Biotech among biotechnology companies — ranked by similarity to what ARTHEx Biotech actually does, not by market-cap band.
Subscribe to see ARTHEx Biotech’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About ARTHEx Biotech
ARTHEx Biotech S.L. is a spin-off company of the University of Valencia dedicated to developing advanced RNA-based treatments against genetic diseases. The company maintains its headquarters in Paterna and Valencia, Spain.
ARTHEx Biotech at a glance
ARTHEx Biotech is a biotechnology company headquartered in Spain. It has raised at least $91.8M across the 2 funding rounds on record. Its most recent funding round, Series B, raised $87M in September 2025. Xcout tracks 12 named people at ARTHEx Biotech, including Frédéric Legros (Executive Chairman & Chief Executive Officer).
ARTHEx Biotech leadership
- Frédéric LegrosExecutive Chairman & Chief Executive Officer
- Beatriz LlamusíChief Scientific Officer & Co-Founder
- Pedro FernándezDirector of Operations
- Glenn SblendorioIndependent Chairman of the Board
- Alain HuriezBoard Member
- Andreas SchmidtBoard Member
6 more named people on record for ARTHEx Biotech, with roles, board committees and tenure — see the full roster →
ARTHEx Biotech funding rounds
At least $91.8M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $87M | 9 named | |
| — | $4.8M | 10 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 ARTHEx Biotech competitors
Ranked by semantic similarity — how close each company is to ARTHEx Biotech by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
ADARx Pharmaceuticals, Inc. is a clinical-stage biotechnology company located in San Diego, California. The company is committed to developing cutting-edge RNA-targeted therapeutics to treat various genetic and severe diseases. ADARx focuses on translating scientific research into life-saving medicines through its proprietary drug discovery pipeline.
Similar biotechnology company
Averna Therapeutics is a biotechnology company developing genomic medicines utilizing RNA and lipid nanoparticle technologies. The company focuses on safe and efficient gene insertion and the treatment of rare genetic diseases through research and development teams located in Boston and Israel.
Similar biotechnology company
Aptadir Therapeutics is a biotechnology company based in Milan, Italy, specializing in the development of RNA inhibitor-based therapeutics. The firm focuses on creating novel treatments for intractable cancers and genetic disorders.
Similar biotechnology company
Phlox Therapeutics is a private biotechnology company pioneering RNA-based gene therapies to alleviate and cure severe genetic heart diseases and cardiomyopathies. Headquartered in Naarden, Netherlands, the company focuses on innovative cardiovascular treatments.
Life Sciences (Therapeutics)
DTx Pharma, Inc. is a privately held biotechnology company based in San Diego, California, that addresses the challenges associated with delivering RNA-based therapeutics.
Similar biotechnology company
Theranexus (THX Pharma) is a clinical-stage biopharmaceutical company that develops innovative therapeutic solutions for patients suffering from rare neurological diseases such as Batten disease, Niemann-Pick type C, and Gaucher disease. The company utilizes scientific research and antisense oligonucleotides to create targeted drug candidates addressing significant unmet medical needs.
Biotech
AAVantgarde Bio is an Italian biotechnology company developing adeno-associated virus (AAV) gene therapies for rare genetic diseases, including conditions caused by genes too large to fit into a single AAV vector. Its technology uses dual-AAV approaches to deliver larger therapeutic genes, serving patients with serious inherited disorders and the clinicians who treat them.
Similar biotechnology company
Argonaute RNA is a therapeutics company headquartered in Bristol, United Kingdom, pursuing opportunities in RNA-based treatments.
Similar biotechnology company
InteRNA Technologies is a venture-backed biotech and life sciences company founded in 2008 and headquartered in Utrecht, Netherlands. The company specializes in the development of microRNA (miRNA)-focused drug pipelines and therapeutics. It operates within the biopharmaceutical sector, supported by various institutional backers and investors.
Similar biotechnology company
SpliSense is an Israeli biotechnology company developing antisense oligonucleotide therapies that correct disease-causing RNA splicing defects. Its programs are aimed at patients with genetic diseases, including specific mutations associated with cystic fibrosis.
Similar biotechnology company
Arcturus Therapeutics Holdings Inc. is a biotechnology company focused on RNA-based medicines, developing a pipeline of vaccines for infectious diseases alongside treatments for rare liver and respiratory conditions across the United States. Its notable development programs encompass LUNAR-OTC, designed for ornithine transcarbamylase (OTC) deficiency, and LUNAR-CF, targeting cystic fibrosis lung disease caused by specific CFTR gene mutations. The company also advances vaccine initiatives such as LUNAR-COV19 and LUNAR-FLU. Arcturus has cultivated a range of strategic collaborations, including partnerships with Vinbiocare Biotechnology Joint Stock Company for manufacturing COVID-19 vaccines; Janssen Pharmaceuticals, Inc., to create nucleic acid-based therapies for hepatitis B virus; Ultragenyx Pharmaceutical, Inc., for developing mRNA therapeutics aimed at rare disease targets; CureVac AG, to progress mRNA therapeutic and vaccine candidates across various indications; the Singapore Economic Development Board and Duke-NUS Medical School, specifically for the LUNAR-COV19 vaccine; and Millennium Pharmaceuticals, Inc., focused on discovering siRNA medicines for non-alcoholic steatohepatitis (NASH). Founded in 2013, Arcturus Therapeutics maintains its corporate headquarters in San Diego, California.
Similar biotechnology company
Mitotherapeutix, LLC is a biotechnology company that develops small interfering RNA (siRNA) based therapeutics targeting difficult disease pathways. The company focuses on modulating mitochondrial metabolic activity by inhibiting a negative gene regulator to treat a wide array of diseases.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of ARTHEx Biotech and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for ARTHEx Biotechand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →